16.07.2025 08:31:34: Sorry, an unexpected error occurred. Please reload the page and try again..

WO2023007320 - LEMBOREXANT FOR USE IN METHODS OF TREATING IRREGULAR SLEEP-WAKE RHYTHM DISORDER AND CIRCADIAN RHYTHM SLEEP DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES

National phase entry:
Publication Number WO/2023/007320
Publication Date 02.02.2023
International Application No. PCT/IB2022/056713
International Filing Date 20.07.2022
Title [English] LEMBOREXANT FOR USE IN METHODS OF TREATING IRREGULAR SLEEP-WAKE RHYTHM DISORDER AND CIRCADIAN RHYTHM SLEEP DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES [French] LEMBOREXANT DESTINÉ À ÊTRE UTILISÉ DANS DES PROCÉDÉS DE TRAITEMENT D'UN TROUBLE DU RYTHME SOMMEIL/RÉVEIL ET DE TROUBLES DU RYTHME CIRCADIEN ASSOCIÉS À DES MALADIES NEURODÉGÉNÉRATIVES
Applicants ** EISAI R&D MANAGEMENT CO., LTD. 6-10 Koishikawa, 4-Chome Bunkyo-ku, Tokyo 112-8088, JP
Inventors ** MOLINE, Margaret 100 Tice Blvd. Woodcliff Lake, New Jersey 07677, US CHENG, Jocelyn Y. 100 Tice Blvd. Woodcliff Lake, New Jersey 07677, US YARDLEY, Jane European Knowledge Center, Mosquito Way Hatfield AL 10 9SN, GB
Priority Data 63/203,512  26.07.2021  US
Application details
International Searching Authority
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country Stages Total
China Filing 1334
EPO Filing, Examination 7922
Japan Filing 554
South Korea Filing 578
USA Filing, Examination 4835
+ Add country
MasterCard Visa
Total: 15223
The term for entry into the National Phase has expired. This quotation is for informational purposes only.

QUOTE TO EMAIL ONLINE QUOTE
Abstract [English] Methods of treating sleep-wake rhythm disorder and related circadian rhythm sleep disorders associated with neurodegenerative diseases are disclosed. [French] L'invention concerne des procédés de traitement d'un trouble du rythme sommeil/réveil et de troubles du rythme circadien associés à des maladies neurodégénératives.